Danang-based Danapha looks to enhance Vietnam pharmaceutical industry’s position: CEO

Danang-based Danapha looks to enhance Vietnam pharmaceutical industry’s position: CEO

Danapha Pharmaceutical JSC (Danapha) has been focusing on high-tech, quality products to export around the world, thus enhancing the position of Vietnam’s pharmaceutical industry, said CEO Le Thang Binh.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7

Foreign investors acquire strategic stakes in Vietnam pharmaceutical firms

Foreign investors acquire strategic stakes in Vietnam pharmaceutical firms

Vietnam's lucrative pharmaceutical industry has seen leading domestic companies like DHG Pharma, Domesco, Traphaco, Imexpharm, Ha Tay Pharmaceutical and Pymepharco attract foreign investors who’ve become strategic shareholders.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7

German pharma giant to ship billions of tablets from Vietnam to Europe

German pharma giant to ship billions of tablets from Vietnam to Europe

German pharmaceutical giant Stada Group will ramp up drugs production at both its Vietnam factories and significantly boost exports to Europe, says CEO Peter Goldschmidt.

Industries - Mon, Dec 22, 2021 | 11:30 am GMT+7

Dongwha Pharm acquires Trung Son Pharma 51% stake for $30 mln

Dongwha Pharm acquires Trung Son Pharma 51% stake for $30 mln

South Korea’s Dongwha Pharm said Thursday it will acquire a 51% stake in Vietnam’s Trung Son Pharma for KRW39.12 billion ($29.86 million).

Industries - Mon, Dec 22, 2021 | 11:30 am GMT+7

Major pharma firms report mixed Q1 profit results

Major pharma firms report mixed Q1 profit results

Vietnam's leading pharma company Hau Giang reported a record after-tax profit in the first quarter of this year, Vinapharm's figure increased by 148%, while Traphaco and OPC posted drops of 10% and 28%, respectively.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7

Bamboo Capital to put more energy into infrastructure, drug sectors

Bamboo Capital to put more energy into infrastructure, drug sectors

Vietnamese conglomerate Bamboo Capital Group is driving its growth based on three core businesses - infrastructure, renewable energy, and real estate - and will invest more in the pharmaceutical sector, the corporation’s leadership said.

Bamboo Capital - Mon, Dec 22, 2021 | 11:30 am GMT+7

DFC pledges $18 mln investment in health firm to expand Vietnam operations

DFC pledges $18 mln investment in health firm to expand Vietnam operations

The U.S. International Development Finance Corporation (DFC) has approved an equity investment of $18 million in BuyMed Pte Ltd. to help the Singapore-registered healthtech firm strengthen its Vietnam operations.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7

Pharmaceutical firm Tipharco posts record after-tax profit in 2022

Pharmaceutical firm Tipharco posts record after-tax profit in 2022

Tipharco Pharmaceutical JSC recorded an after-tax profit of VND18.2 billion ($773,600) in 2022, 19 times higher than the previous year and the highest since its establishment in 1976 after joining Bamboo Capital Group nearly a year ago.

Bamboo Capital - Mon, Dec 22, 2021 | 11:30 am GMT+7

Vietnam pharma firms report healthy earnings in 2022

Vietnam pharma firms report healthy earnings in 2022

Major pharma companies Traphaco, Mekophar, Hau Giang, OPC and Imexpharm all posted healthy profits last year thanks to high domestic demand for drugs, according to their financial statements.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7

Vietnam's leading pharma firms post bumper profits in 2022

Vietnam's leading pharma firms post bumper profits in 2022

Hau Giang Pharmaceutical JSC, OPC Pharmaceutical JSC, and Imexpharm Corporation reported huge profits last year thanks to high demand for drugs, according to their financial statements.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7

Pharma market needs innovations to cope with fragmented supply chain

Pharma market needs innovations to cope with fragmented supply chain

The Covid-19 pandemic has led to changes in the perception and behavior of pharma consumers. Hoang Nguyen, CEO and co-founder of Buymed Co. Ltd., the operator of medicine e-commerce platform thuocsi.vn, talks to The Investor about the startup's innovations and opportunities arising for healthcare businesses in this context.

Executive Talk - Mon, Dec 22, 2021 | 11:30 am GMT+7

DHG Pharma reports average monthly profit of $3.9 mln, up 20%

DHG Pharma reports average monthly profit of $3.9 mln, up 20%

DHG Pharmaceutical JSC, Vietnam's leading pharmaceutical, recorded a pre-tax profit of VND546 billion ($23.3 million) in the first six months of the year, up 20.5% year-on-year, or an average monthly profit of $3.9 million.

Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7